Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Karnon

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Health Economics|February 17, 2001
Economic evaluation alongside n-of-1 trials: getting closer to the marginJ Karnon, N Qizilbash
Health Care Management Science|August 1, 2000
Selecting a decision model for economic evaluation: a case study and reviewJ Karnon, J Brown
Journal of Health Services Research & Policy|February 24, 2001
Cost analysis of a hospital-at-home initiative using discrete event simulationH Campbell, J Karnon, R Dowie
The Journal of Hospital Infection|April 4, 2023
Pragmatic review of interventions to prevent catheter-associated urinary tract infections (CAUTIs) in adult inpatientsJ Gray, A Rachakonda, J Karnon
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
Clinical Pharmacology and Therapeutics|June 22, 2011
The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of prasugrelC Y Lu, J Karnon, M J Sorich
Critical Reviews in Oncology/Hematology|December 28, 1999
Using modelling in a phased approach to the economic evaluation of adjuvant therapy for early breast cancer. ABC Trial Steering CommitteeJ Brown, J Karnon, T Eldabi, et al.
Archives of Disease in Childhood|August 26, 2003
Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomJ Brown, C Dezateux, J Karnon, et al.
Archives of Disease in Childhood|August 26, 2003
Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomC Dezateux, J Brown, R Arthur, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
The role of modelling in prioritising and planning clinical trialsJ Chilcott, A Brennan, A Booth, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Health Economics|February 17, 2001
Economic evaluation alongside n-of-1 trials: getting closer to the marginJ Karnon, N Qizilbash
Health Care Management Science|August 1, 2000
Selecting a decision model for economic evaluation: a case study and reviewJ Karnon, J Brown
Journal of Health Services Research & Policy|February 24, 2001
Cost analysis of a hospital-at-home initiative using discrete event simulationH Campbell, J Karnon, R Dowie
The Journal of Hospital Infection|April 4, 2023
Pragmatic review of interventions to prevent catheter-associated urinary tract infections (CAUTIs) in adult inpatientsJ Gray, A Rachakonda, J Karnon
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
Clinical Pharmacology and Therapeutics|June 22, 2011
The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of prasugrelC Y Lu, J Karnon, M J Sorich
Critical Reviews in Oncology/Hematology|December 28, 1999
Using modelling in a phased approach to the economic evaluation of adjuvant therapy for early breast cancer. ABC Trial Steering CommitteeJ Brown, J Karnon, T Eldabi, et al.
Archives of Disease in Childhood|August 26, 2003
Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomJ Brown, C Dezateux, J Karnon, et al.
Archives of Disease in Childhood|August 26, 2003
Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomC Dezateux, J Brown, R Arthur, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
The role of modelling in prioritising and planning clinical trialsJ Chilcott, A Brennan, A Booth, et al.
Pageof 4